Carbamylated Erythropoietin Reduces Radiosurgically-Induced Brain Injury
Serhat Erbayraktar(University of Messina), Michael Brines(Northwell Health), Zübeyde Erbayraktar, Anthony Cerami(Araim Pharmaceuticals (United States)), Nihal de Lanerolle(Yale University), Jonathan Knisely(Apple (Israel)), Alain de Lotbinière(Yale University), Thomas R. Coleman(University of Messina), Osman Yılmaz(University of Messina)
Cited by 55
Related Papers
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
|International Journal of Radiation Oncology*Biology*Physics|2009|984